Peter S. Nelson

Also affiliated with Fred Hutch Cancer Center, University of Washington Applied Physics Laboratory

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.418Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.18.629070

Top 44%

0.418DataRank

Top 44%10 citations

Jianming Zeng, Canping Chen, Xiaofan Zhao, Tingting Zhang, George Thomas +7 more

Papers

Driven by 105 papers — median percentile 28. Top paper: “Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer”.

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

Nature Communications(2021)10.1038/s41467-021-26042-z

N/A

2.9DataRank · unranked

163 citations

Yingtian Xie, Alba Font‐Tello, Klothilda Lim, Sudeepa Syamala, Xintao Qiu +33 more

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer

JCI Insight(2021)10.1172/jci.insight.146827

N/A

1.5DataRank · unranked

58 citations

Yezi Zhu, Ilsa M. Coleman, Susan L. Dalrymple, Lizamma Antony, Radhika A. Patel +16 more

Defining cellular population dynamics at single-cell resolution during prostate cancer progression

eLife(2022)10.7554/elife.79076

N/A

1.1DataRank · unranked

29 citations

Sonali Arora, Ye Zheng, Erica T. Goddard, Ilsa M. Coleman, Anson T. Ku +17 more

ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer

Nucleic Acids Research(2024)10.1093/nar/gkae547

N/A

0.703DataRank · unranked

36 citations

Qian Yang, Mirja Rotinen, Rongrong Huang, Hyo‐Young Kim, Brad Gallent +21 more

Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer

Cell Reports(2024)10.1016/j.celrep.2024.115089

N/A

0.455DataRank · unranked

12 citations

Mannan Nouri, Jiaqian Liang, Shaoyong Chen, Andreas Varkaris, Betul Ersoy-Fazlioglu +15 more

Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.18.629070

Top 44%

0.418DataRank

Top 44%10 citations

Jianming Zeng, Canping Chen, Xiaofan Zhao, Tingting Zhang, George Thomas +7 more

Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0069

N/A

0.288DataRank · unranked

5 citations

Roman Gulati, Erolcan Sayar, Radhika A. Patel, Pushpa Itagi, Helen Richards +25 more

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer

PLoS ONE(2020)10.1371/journal.pone.0239686

N/A

0DataRank · unranked

10 citations

Rigo I. Acevedo, Daniel M. Lim, Roman Gulati, Agnes Gawne, Alexandra Sokolova +6 more

Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4

Neoplasia(2020)10.1016/j.neo.2020.04.002

N/A

0DataRank · unranked

29 citations

David A. Sampson, Archana Sehrawat, Anbarasu Kumaraswamy, Duanchen Sun, Yuzhuo Wang +12 more

Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer

(2020)10.1101/2020.09.13.291328

N/A

0DataRank · unranked

21 citations

Yingtian Xie, Alba Font‐Tello, Klothilda Lim, Sudeepa Syamala, Xintao Qiu +30 more

A pilot study of docetaxel and carboplatin for treatment of patients with mCRPC containing biallelic inactivation of genes in the BRCA1/2 pathway.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.127

N/A

0DataRank · unranked

2 citations

Makayla DeJong, Evan Y. Yu, Roman Gulati, Matthew B. Rettig, Celestia S. Higano +4 more

Treatment response comparisons between ATM and BRCA2 germline carriers for mCRPC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.63

N/A

0DataRank · unranked

2 citations

Catherine H. Marshall, Rebeca Lozano, Petros Grivas, Celestia S. Higano, Tamara L. Lotan +11 more

Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling

Nature Communications(2021)10.1038/s41467-021-21615-4

N/A

0DataRank · unranked

299 citations

Michelle Kriner, Ilsa M. Coleman, Colm Morrissey, Martine P. Roudier, Lawrence D. True +10 more

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer

Nature Communications(2021)10.1038/s41467-021-22139-7

N/A

0DataRank · unranked

171 citations

David Y. Takeda, Ji-Heui Seo, Justin H. Hwang, Sheng-Yu Ku, Rand Arafeh +36 more

Multiplexed functional genomic analysis of 5’ untranslated region mutations across the spectrum of prostate cancer

Nature Communications(2021)10.1038/s41467-021-24445-6

N/A

0DataRank · unranked

76 citations

Sonali Arora, Samantha L. Schuster, Lukas Corey, Matthew Fitzgibbon, Cynthia L. Wladyka +9 more

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

Cancer Research(2021)10.1158/0008-5472.can-21-0307

N/A

0DataRank · unranked

53 citations

Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Nicholas J. Brady, John K. Lee +13 more

Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer

The Journal of Pathology(2021)10.1002/path.5781

N/A

0DataRank · unranked

38 citations

Alba FC Torres, Juhyung Woo, Thiago Vidotto, Harrison Tsai, Jun Luo +9 more

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

Journal of Clinical Investigation(2021)10.1172/jci146777

N/A

0DataRank · unranked

40 citations

Lisa S. Ang, Alexandra Corella, Ilsa M. Coleman, Michael P. Meers, Anthony Christiani +16 more

Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer

JCI Insight(2021)10.1172/jci.insight.152789

N/A

0DataRank · unranked

36 citations

Sayan Dasgupta, Payel Chatterjee, Ilsa M. Coleman, Gavin Ha, Lisa S. Ang +17 more

Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2103623118

N/A

0DataRank · unranked

30 citations

Claudia Paindelli, Luis Díaz‐Gómez, Anthony J. Melchiorri, Antonios G. Mikos, Peter S. Nelson +3 more

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer

Cancer(2021)10.1002/cncr.33911

N/A

0DataRank · unranked

8 citations

Kehao Zhu, Yingye Zheng, Lisa F. Newcomb, Jeannette M. Schenk, James D. Brooks +15 more

Multilineage plasticity in prostate cancer through expansion of stem–like luminal epithelial cells with elevated inflammatory signaling

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.01.466599

N/A

0DataRank · unranked

7 citations

Jimmy L. Zhao, Joseph M. Chan, Martine P. Roudier, Kristine M. Wadosky, Anuradha Gopalan +25 more

Harbingers of Aggressive Prostate Cancer: Precision Oncology Case Studies

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.30.468210

N/A

0DataRank · unranked

0 citations

Davide Prandi, Arshi Arora, Daniel H. Hovelson, Andrea Sboner, Antonio Rodrı́guez +13 more

A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA

Nature Communications(2022)10.1038/s41467-022-35076-w

N/A

0DataRank · unranked

130 citations

Minjeong Ko, Hanna Liao, A. Eden Cruikshank, Katheryn Santos, Caroline Kikawa +18 more

Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0692

N/A

0DataRank · unranked

70 citations

Robert D. Patton, Anna-Lisa Doebley, Brian Hanratty, Mohamed Adil, Adam J. Kreitzman +28 more

Unchecked oxidative stress in skeletal muscle prevents outgrowth of disseminated tumour cells

Nature Cell Biology(2022)10.1038/s41556-022-00881-4

N/A

0DataRank · unranked

58 citations

Travis Nemkov, Ruth F. Dumpit, Jinxiang Dai, Stephen J. Tapscott, Lawrence D. True +6 more

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4289

N/A

0DataRank · unranked

42 citations

Navonil De Sarkar, Colm Morrissey, Li Zhang, Martine P. Roudier, Erolcan Sayar +5 more

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0851

N/A

0DataRank · unranked

32 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

Patterns of structural variation define prostate cancer across disease states

JCI Insight(2022)10.1172/jci.insight.161370

N/A

0DataRank · unranked

28 citations

Minjeong Ko, Anna C. H. Hoge, Kelsey Luu, Yuzhen Liu, Magdalena L Russell +13 more

Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies

The Journal of Pathology(2022)10.1002/path.5887

N/A

0DataRank · unranked

26 citations

Davide Prandi, Arshi Arora, Daniel H. Hovelson, Andrea Sboner, Antonio Rodrı́guez +13 more

Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis

Human Pathology(2022)10.1016/j.humpath.2022.01.009

N/A

0DataRank · unranked

25 citations

Yan Gao, Yi Ding, Ping Bu, Brian J. Miles, Angelo De Marzo +25 more

Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-022-00636-0

N/A

0DataRank · unranked

23 citations

Roman Gulati, Todd Yezefski, Heather H. Cheng, Elahe A. Mostaghel, Michael C. Haffner +17 more

Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer

Nature Communications(2022)10.1038/s41467-022-32530-7

N/A

0DataRank · unranked

19 citations

Chris Kedong Wang, Htoo Zarni Oo, Irina Nelepcu, Nada Lallous, Charlotte B. Spliid +21 more

Endocrine and paracrine characteristics of neuroendocrine prostate cancer

Frontiers in Endocrinology(2022)10.3389/fendo.2022.1012005

N/A

0DataRank · unranked

18 citations

Peter S. Nelson, Tarana Arman

Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome

JCI Insight(2022)10.1172/jci.insight.157164

N/A

0DataRank · unranked

19 citations

Lisha G. Brown, Jennifer L. Conner, Holly M. Nguyen, Nadia Boufaied, Sarah Abou Alaiwi +15 more

Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations

Cancer Research Communications(2022)10.1158/2767-9764.crc-21-0156

N/A

0DataRank · unranked

15 citations

Ilsa Coleman, Martine P. Roudier, Eric Q. Konnick, Brian Hanratty, Ruth F. Dumpit +13 more

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance

Cancer Medicine(2022)10.1002/cam4.4778

N/A

0DataRank · unranked

10 citations

Lisa F. Newcomb, Kehao Zhu, Yingye Zheng, Hilary Boyer, Navonil De Sarkar +16 more

Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.21.496879

N/A

0DataRank · unranked

8 citations

Robert D. Patton, Anna-Lisa Doebley, Brian Hanratty, Adam J. Kreitzman, Jay F. Sarthy +28 more

Patterns of Structural Variation Define Prostate Cancer Across Disease States

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.09.475586

N/A

0DataRank · unranked

4 citations

Minjeong Ko, Anna C. H. Hoge, Kelsey Luu, Yuzhen Liu, Magdalena L Russell +13 more

Rates of germline genetic testing and DNA damage response mutations found through population-based recruitment of men with incident metastatic prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10501

N/A

0DataRank · unranked

3 citations

Risa Liang Wong, Burcu F. Darst, Colin C. Pritchard, Peter S. Nelson, Janet L. Stanford +3 more

Defining cellular population dynamics at single cell resolution during prostate cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.02.482711

N/A

0DataRank · unranked

2 citations

Sonali Arora, Ye Zheng, Erica T. Goddard, Ilsa M. Coleman, Anson T. Ku +13 more

Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer

medRxiv(2022)10.1101/2022.03.10.22271799

N/A

0DataRank · unranked

2 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

A human prefrontal cortex tissue microarray to study Alzheimer’s disease

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r5709

N/A

0DataRank · unranked

0 citations

Tara R. Hawkinson, Harrison A. Clarke, Lyndsay E.A. Young, Peter S. Nelson, Matthew S. Gentry +2 more

Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy

Nature Communications(2023)10.1038/s41467-023-37874-2

N/A

0DataRank · unranked

127 citations

Nikhil Kamat, Tiffany E. Pariva, Liting Wu, Annabelle Tsao, Koichi Sasaki +19 more

Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer

JCI Insight(2023)10.1172/jci.insight.162907

N/A

0DataRank · unranked

82 citations

Radhika A. Patel, Ilsa M. Coleman, Martine P. Roudier, Ailin Zhang, Pallabi Mustafi +20 more

Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation

Cancer Cell(2023)10.1016/j.ccell.2023.10.009

N/A

0DataRank · unranked

75 citations

Wendy Tran, Kai Song, Tyler Sugimoto, Matthew B. Obusan, Liang Wang +20 more

Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0754

N/A

0DataRank · unranked

62 citations

Orsetta Quaini, Kei Mizuno, Francesco Orlando, Yari Ciani, Sheng-Yu Ku +23 more

Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment

Nature Cell Biology(2023)10.1038/s41556-023-01274-x

N/A

0DataRank · unranked

37 citations

Preston D. Crowell, Amelie M.L. Delcourt, Takao Hashimoto, Sung Min Ha, Aishwarya Atmakuri +17 more

Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models

Journal of Clinical Investigation(2023)10.1172/jci162148

N/A

0DataRank · unranked

32 citations

Lei Fang, Kerry M. McGowen, JuanJuan Yin, Joel Bowman, Anson T. Ku +17 more

SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer

Nature Communications(2023)10.1038/s41467-023-43245-8

N/A

0DataRank · unranked

21 citations

Dmytro Rudoy, Sander B. Frank, Luan T. Phan, Olga Klezovitch, Julian Kwan +7 more

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.11.014

N/A

0DataRank · unranked

18 citations

Fadi Taza, Navonil De Sarkar, Alok K. Tewari, Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz +32 more

Characterization of HOXB13 expression patterns in localized and metastatic castration‐resistant prostate cancer

The Journal of Pathology(2023)10.1002/path.6216

N/A

0DataRank · unranked

26 citations

Erolcan Sayar, Ilsa Coleman, Martine P. Roudier, Brian Hanratty, Jin‐Yih Low +23 more

Clinical, pathologic, and molecular features of amphicrine prostate cancer

The Prostate(2023)10.1002/pros.24497

N/A

0DataRank · unranked

25 citations

Michael C. Haffner, Erolcan Sayar, Agnes Gawne, Michael T. Schweizer, Colin C. Pritchard +4 more

Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0250

N/A

0DataRank · unranked

19 citations

Nathan A. Lau, Alicia Wong, Lisha G. Brown, Ilsa M. Coleman, Navonil De Sarkar +14 more

Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer

The Prostate(2023)10.1002/pros.24630

N/A

0DataRank · unranked

12 citations

Lisha G. Brown, Ilsa M. Coleman, Holly M. Nguyen, Susan L. Dalrymple, W. Nathaniel Brennen +11 more

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex

Cancer Research(2023)10.1158/0008-5472.can-22-2613

N/A

0DataRank · unranked

11 citations

Ilsa M. Coleman, Jared M. Lucas, Dapei Li, Brian Hanratty, Hannah Meade +6 more

Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study

Modern Pathology(2023)10.1016/j.modpat.2023.100241

N/A

0DataRank · unranked

8 citations

Stephanie A. Harmon, Rachael Iseman, Olga Ludkowski, Heidi Auman, Sarah T. Hawley +28 more

Pharmacological NF‐κB inhibition decreases cisplatin chemoresistance in muscle‐invasive bladder cancer and reduces cisplatin‐induced toxicities.

Molecular Oncology(2023)10.1002/1878-0261.13504

N/A

0DataRank · unranked

10 citations

Christine Levesque, Daniella Bianchi‐Frias, Payel Chatterjee, Hung‐Ming Lam, Carlos Santos +20 more

Third generation quinoline‐3‐carboxamide transcriptional disrupter of HDAC4, HIF‐1α, and MEF‐2 signaling for metastatic castration‐resistant prostate cancer

The Prostate(2023)10.1002/pros.24606

N/A

0DataRank · unranked

5 citations

Susan L. Dalrymple, Lizamma Antony, David M. Rosen, Ilsa M. Coleman, Peter S. Nelson +7 more

PSMA expression and response to 177Lu-PSMA-617 (LuPSMA) in men with vs. without DNA damage repair (DDR) mutations.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5055

N/A

0DataRank · unranked

6 citations

George Mo, Michael C. Haffner, Colm Morrissey, Gavin Ha, Evan Y. Yu +9 more

Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular Correlates

Research Square(2023)10.21203/rs.3.rs-3745991/v1

N/A

0DataRank · unranked

4 citations

Azra Ajkunic, Erolcan Sayar, Martine P. Roudier, Radhika A. Patel, Ilsa M. Coleman +22 more

Final results of a pilot study of docetaxel and carboplatin for treatment of patients with mCRPC containing biallelic inactivation of genes in the homologous recombination DNA repair pathway.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5054

N/A

0DataRank · unranked

2 citations

Makayla DeJong, Evan Y. Yu, Roman Gulati, Matthew B. Rettig, Peter S. Nelson +4 more

Data from Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer

(2023)10.1158/1078-0432.c.6530156.v1

N/A

0DataRank · unranked

0 citations

Thomas M. Cardillo, Lisa S. Ang, Mark P. Labrecque, Ailin Zhang, James E. Hopkins +11 more

Data from Prostate Cancer–Associated Gene Expression Alterations Determined from Needle Biopsies

(2023)10.1158/1078-0432.c.6517968.v1

Top 100%

0DataRank

Top 100%0 citations

Chung‐Ying Huang, Catherine O′Brien, Ilsa M. Coleman, Mark Garzotto, Lawrence D. True +6 more

Data from Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

(2023)10.1158/1078-0432.c.6532445

N/A

0DataRank · unranked

0 citations

Ines Figueiredo, Rosina T. Lis, Ilsa M. Coleman, Bora Gurel, Denisa Bogdan +26 more

Data from WDR19 Expression is Increased in Prostate Cancer Compared with Normal Cells, but Low-Intensity Expression in Cancers is Associated with Shorter Time to Biochemical Failures and Local Recurrence

(2023)10.1158/1078-0432.c.6518298

N/A

0DataRank · unranked

0 citations

Angelita G. Utleg, Karsten Gravdal, James T. White, Ole J. Halvorsen, Wei Lü +8 more

Data from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes

(2023)10.1158/2159-8290.c.6549837.v1

N/A

0DataRank · unranked

0 citations

Robert D. Patton, Anna-Lisa Doebley, Brian Hanratty, Mohamed Adil, Adam J. Kreitzman +28 more

Data from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes

(2023)10.1158/2159-8290.c.6549837.v2

N/A

0DataRank · unranked

0 citations

Robert D. Patton, Anna-Lisa Doebley, Brian Hanratty, Mohamed Adil, Adam J. Kreitzman +28 more

Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs

Journal of Clinical Investigation(2024)10.1172/jci168649

N/A

0DataRank · unranked

41 citations

Maryam Labaf, Yawei Zhao, Jude Owiredu, Songqi Zhang, Krishna Patel +25 more

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates

npj Precision Oncology(2024)10.1038/s41698-024-00599-6

N/A

0DataRank · unranked

32 citations

Erolcan Sayar, Martine P. Roudier, Radhika A. Patel, Ilsa M. Coleman, Navonil De Sarkar +24 more

Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage

Histopathology(2024)10.1111/his.15231

N/A

0DataRank · unranked

30 citations

Lara R. Harik, Eric A. Klein, Jianbo Li, Dillon Corrigan, Shiguang Liu +18 more

Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2061

N/A

0DataRank · unranked

27 citations

Michael J. Morris, Chien‐Kuang Cornelia Ding, Erolcan Sayar, Rohit Mehra, Brian D. Robinson +10 more

Y Chromosome Loss and Implications for Oncology

Molecular Cancer Research(2024)10.1158/1541-7786.mcr-24-0105

N/A

0DataRank · unranked

18 citations

Peter S. Nelson, Canan Dirican

Defining the challenges and opportunities for using patient‐derived models in prostate cancer research

The Prostate(2024)10.1002/pros.24682

N/A

0DataRank · unranked

10 citations

Clémentine Le Magnen, Sofia Karkampouna, Nicolás Anselmino, Nathalie Bock, Nicholas Choo +20 more

Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts

Molecular Cancer Research(2024)10.1158/1541-7786.mcr-23-0976

N/A

0DataRank · unranked

14 citations

Abderrahman Day, Hannah E. Bergom, Gabrianne Larson, Atef Ali, Megan Ludwig +8 more

Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study

JCO Precision Oncology(2024)10.1200/po.23.00634

N/A

0DataRank · unranked

14 citations

George Mo, Abuzar Moradi Tuchayi, Laura Graham, Roman Gulati, Colin C. Pritchard +13 more

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

Scientific Reports(2024)10.1038/s41598-023-50215-z

N/A

0DataRank · unranked

11 citations

Sarah Hawley, Christian A. Kunder, En‐Chi Hsu, Michelle Shen, Lennart Westphalen +17 more

Small-molecule disruption of androgen receptor–dependent chromatin clusters

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2406239121

N/A

0DataRank · unranked

4 citations

EK Novak, Subhashish Tapadar, Bocheng Wu, Jonathan D. Strope, Yaw Asante +25 more

Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial

European Urology(2024)10.1016/j.eururo.2024.05.025

N/A

0DataRank · unranked

3 citations

Makayla DeJong, Matthew B. Rettig, Evan Y. Yu, Roman Gulati, Michael T. Schweizer +5 more

Single-nucleus multiome analysis of human cerebellum in Alzheimer’s disease-related dementia

Research Square(2024)10.21203/rs.3.rs-4871032/v1

N/A

0DataRank · unranked

4 citations

Yayan Feng, Margaret E. Flanagan, Borna Bonakdarpour, Pouya Jamshidi, Rudolph J. Castellani +12 more

Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.10.575110

N/A

0DataRank · unranked

1 citations

Mannan Nouri, Jiaqian Liang, Andreas Varkaris, Betul Ersoy-Fazlioglu, Olga Voznesensky +14 more

Probing tau citrullination in Alzheimer’s disease brains and mouse models of tauopathy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.06.601399

N/A

0DataRank · unranked

1 citations

Jerry B. Hunt, Chao Ma, Andrii Kovalenko, John Calahatian, Cecelie Pedersen +20 more

High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1509

N/A

0DataRank · unranked

15 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, V. Carreño +31 more

Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer

Journal of Clinical Investigation(2025)10.1172/jci186599

N/A

0DataRank · unranked

10 citations

Roman Gulati, Erolcan Sayar, Radhika A. Patel, Micah Tratt, Helen Richards +40 more

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer

Nature Genetics(2025)10.1038/s41588-025-02388-8

N/A

0DataRank · unranked

6 citations

James E. Melnyk, Becky Xu Hua Fu, Raunak Shrestha, Meng Zhang, Martin Sjöström +34 more

PROX1 is an early driver of lineage plasticity in prostate cancer

Journal of Clinical Investigation(2025)10.1172/jci187490

N/A

0DataRank · unranked

9 citations

Mingchen Shi, Anbarasu Kumaraswamy, Dong Lin, Dhruv Khokhani, Yong Wang +41 more

OmicsTweezer: A distribution-independent cell deconvolution model for multi-omics Data

Cell Genomics(2025)10.1016/j.xgen.2025.100950

N/A

0DataRank · unranked

7 citations

Faming Zhao, Tao Ren, Canping Chen, Katelyn T. Byrne, Alexey V. Danilov +6 more

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

Nature Communications(2025)10.1038/s41467-025-64042-5

N/A

0DataRank · unranked

6 citations

Daniel Westaby, Ines Figueiredo, Alexis de Haven Brandon, Ana Padilha, Wei Yuan +53 more

Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer

Oncogene(2025)10.1038/s41388-025-03631-6

N/A

0DataRank · unranked

3 citations

Zhicheng Zhou, Yiqun Zhang, Deyong Jia, Ding Wang, Mary C. Reiger +6 more

Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes

European Urology Oncology(2025)10.1016/j.euo.2025.01.002

N/A

0DataRank · unranked

6 citations

Abuzar Moradi Tuchayi, Soon Khai Low, Ali T. Arafa, Laura Graham, Roman Gulati +15 more

Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosis

Histopathology(2025)10.1111/his.70033

N/A

0DataRank · unranked

2 citations

Erolcan Sayar, Michael T. Schweizer, Stephanie A. Harmon, Colm Morrissey, Himisha Beltran +5 more

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants

European Urology Focus(2025)10.1016/j.euf.2025.03.017

N/A

0DataRank · unranked

3 citations

Shivakumar Keerthikumar, Scott L. Townley, Ashlee K. Clark, Georgia B. Cuffe, Geraldine Laven‐Law +17 more

Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair Deficiency

European Urology Oncology(2025)10.1016/j.euo.2025.04.026

N/A

0DataRank · unranked

2 citations

Heather H. Cheng, Roman Gulati, Michael T. Schweizer, Aaron Lin, Todd Yezefski +7 more

Identifying prognostic targets in metastatic prostate cancer beyond AR

FEBS Open Bio(2025)10.1002/2211-5463.70059

N/A

0DataRank · unranked

1 citations

Eric Feng, Tracy J. Berg, Isabella Nguyen, Lilac Nguyen, William Chen +9 more

Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology

Journal of Clinical Investigation(2025)10.1172/jci194727

N/A

0DataRank · unranked

1 citations

Armand Bankhead, Ilsa M. Coleman, Thomas Persse, Wanting Han, Patricia C. Galipeau +15 more

LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer

Neoplasia(2025)10.1016/j.neo.2025.101151

N/A

0DataRank · unranked

1 citations

Rahul Mannan, Olivia A Swaim, Eva S. Rodansky, Xiaoming Wang, Aaron M. Udager +10 more

Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.02.12.637904

N/A

0DataRank · unranked

4 citations

Kai Song, Huiyun Sun, Yong Tao, Arthur Huang, Vipul Bhatia +9 more

Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference

JAMA Oncology(2020)10.1001/jamaoncol.2020.5161

N/A

0DataRank · unranked

160 citations

Eric Q. Konnick, Michael T. Schweizer, Alexandra Sokolova, Petros Grivas, Heather H. Cheng +7 more

Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.02.657429

N/A

0DataRank · unranked

2 citations

Esmé Wheeler, Rong Li, Feng Lü, Buraq Ahmed, Alok K. Tewari +8 more

Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors

Oncogene(2020)10.1038/s41388-020-01479-6

N/A

0DataRank · unranked

105 citations

Susan L. Dalrymple, Ilsa M. Coleman, Shun Zheng, Jianfeng Xu, Jody E. Hooper +10 more

Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3396

N/A

0DataRank · unranked

88 citations

Thomas M. Cardillo, Lisa S. Ang, Mark P. Labrecque, Ailin Zhang, James E. Hopkins +11 more

Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1358

N/A

0DataRank · unranked

69 citations

Joseph P. Gallant, Donald J. Vander Griend, Ilsa M. Coleman, Peter S. Nelson, Aaron M. LeBeau +1 more

Targeting RET Kinase in Neuroendocrine Prostate Cancer

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-19-1245

N/A

0DataRank · unranked

51 citations

Johnny R. Ramroop, Katherine L. Morel, Song Yi Bae, Anjali V. Sheahan, Zoi E. Sychev +17 more

Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001510

N/A

0DataRank · unranked

21 citations

Tun Lee Ng, Michael A. Newton, Jin Zhang, Christopher A. Maher, Peter S. Nelson +2 more

A comparison of prostate cancer cell transcriptomes in 2D monoculture vs 3D xenografts identify consistent gene expression alterations associated with tumor microenvironments

The Prostate(2020)10.1002/pros.23963

N/A

0DataRank · unranked

18 citations

Rui M. Gil da Costa, Ilsa M. Coleman, Clinton K. Matson, Michael Risk, Roger Coleman +2 more

Peter S. Nelson

Indexed papers

Top data-sharing exemplar

Papers